Cargando…
Trans‐generational epigenetic regulation associated with the amelioration of Duchenne Muscular Dystrophy
Exon skipping is an effective strategy for the treatment of many Duchenne Muscular Dystrophy (DMD) mutations. Natural exon skipping observed in several DMD cases can help in identifying novel therapeutic tools. Here, we show a DMD study case where the lack of a splicing factor (Celf2a), which result...
Autores principales: | Martone, Julie, Lisi, Michela, Castagnetti, Francesco, Rosa, Alessandro, Di Carlo, Valerio, Blanco, Enrique, Setti, Adriano, Mariani, Davide, Colantoni, Alessio, Santini, Tiziana, Perone, Lucia, Di Croce, Luciano, Bozzoni, Irene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7411655/ https://www.ncbi.nlm.nih.gov/pubmed/32596946 http://dx.doi.org/10.15252/emmm.202012063 |
Ejemplares similares
-
miRNAs as serum biomarkers for Duchenne muscular dystrophy
por: Cacchiarelli, Davide, et al.
Publicado: (2011) -
SMaRT lncRNA controls translation of a G‐quadruplex‐containing mRNA antagonizing the DHX36 helicase
por: Martone, Julie, et al.
Publicado: (2020) -
Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012) -
Theragnosis for Duchenne Muscular Dystrophy
por: Luce, Leonela, et al.
Publicado: (2021) -
Quantifying the burden of caregiving in Duchenne muscular dystrophy
por: Landfeldt, Erik, et al.
Publicado: (2016)